Table 4 Summary of clinical outcomes between the groups with or without cysts.
From: Is there added risk in resurfacing a femoral head with cysts?
Study Group -- with Cyst | Control Group -- Without Cyst | P-Value | |
|---|---|---|---|
Period of follow-up (months) | 42 ± 11 (range: 24 to 61) | 45 ± 12 (range: 24 to 65) | 0.08 |
Pre-operative information | |||
HHS score | 54 ± 12 (range: 24 to 91) | 55 ± 13 (range: 21 to 83) | 0.2 |
Post-operative information | |||
HHS score | 97 ± 6 (range: 68 to 100) | 95 ± 8 (range: 71 to 100) | 0.22 |
UCLA score | 8 ± 2 (range: 4 to 10) | 8 ± 2 (range: 3 to 10) | 0.95 |
VAS score in the regular day | 0 ± 1 (range: 0 to 4) | 0 ± 1 (range: 0 to 4) | 0.59 |
VAS score in the worst day | 1 ± 2 (range: 0 to 8) | 1 ± 2 (range: 0 to 7) | 0.27 |
Femoral radiolucency | 0 (0%) | 0 (0%) | 1 |
Number of femoral failures (revisions) | 3 (3%) | 0 (0%) | 0.08 |
Deceased | 0 (0%) | 2 (1.7%) | 0.16 |